Vas Narasimhan and Severin Schwan each claimed pay packets worth $12M+ for 2021

Two of the top paid European pharma CEOs have reported their income for 2021. And while both could boast of some hefty pay packages for the year behind us, the numbers are likely to be dwarfed as the US execs — including some leaders of much smaller biotechs — begin to report their compensation later in the year.

Roche CEO Severin Schwan jumped into the lead in this first cut of the income numbers, though not by much. His compensation package rang up to 11.5 million CHF ($12.4 million). And Vas Narasimhan, who took the helm at Novartis just 4 years ago, claimed 11.2 million ($12 million) CHF.